Ceftriaxone Sodium

Product NDC: 60505-6152
11-digit product format: 605056152
Labeler code: 60505
Product ID: 60505-6152_0432e6c3-ad77-726c-e063-6294a90a798c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ceftriaxone Sodium
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Apotex Corp.
Application: ANDA203702
Marketing category: ANDA
Marketing start: 2017-06-30
Substance: CEFTRIAXONE SODIUM
Active strength: 500 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203702-001	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29
A203702-002	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29
A203702-003	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29
A203702-004	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A203702-001	AP
A203702-002	AP
A203702-003	AP
A203702-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A203702-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-003	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-004	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203702-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203702-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-004	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-004	AP	1	`d8e5a09893c0…`

Additional Listing Data#

Finished product: Yes
Brand name base: Ceftriaxone Sodium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFTRIAXONE SODIUM	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
023Z5BR09K	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309092	Internal RxNorm lookup
1665005	Internal RxNorm lookup
1665021	Internal RxNorm lookup
1665046	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5116231f-82d1-44be-b08e-560c9a50e5c5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
67ae10d0-6c6a-4d52-a629-da83321859b9	Product name	3	20190201
01b0d089-049b-4c6d-8dfe-1bffad9be307	Product name	2	20180807
2d5083fe-71de-4fce-8d67-e9049cba775c	Product name	1	20150107
1037f4ca-3bea-c9c4-2af4-fa6387b0e81e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
60505-6152-1	Ceftriaxone Sodium	1 in 1 VIAL, SINGLE-USE	INJECTION, POWDER, FOR SOLUTION	1	11
60505-6152-1	Ceftriaxone Sodium	10 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	10	11
60505-6152-4	Ceftriaxone Sodium	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1	11
60505-6152-4	Ceftriaxone Sodium	1 in 1 VIAL, SINGLE-USE	INJECTION, POWDER, FOR SOLUTION	1	11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60505-6152-1	EA - Each	60505-6152	bd13c170-47ed-418c-8d90-899a398ed6ab	1	2017-07-07
60505-6152-4	EA - Each	60505-6152	943a5c92-d054-40ec-8f8b-2961d85c6ca5	1	2017-07-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60505-6152	CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [APOTEX CORP.]	11	Current NDC, Legacy NDC, 4 package rows	20230831_5116231f-82d1-44be-b08e-560c9a50e5c5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	85ce4f8b-77e0-48bf-9f57-93f1478befa2	2026-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	9a937e47-8c36-4656-83e1-b3c18ed9bac3	2026-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Qilu Pharmaceutical Co., Ltd.	4cdf0743-c62b-4969-b9c9-4c6400644f6c	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	A-S Medication Solutions	53415af6-4072-4339-83e2-d870ae02a0e2	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Proficient Rx LP	790279d4-2456-4091-abec-960b78885432	2024-02-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Asclemed USA, Inc.	f01cf0e5-caaf-4759-ba21-50f3aceff523	2023-09-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Apotex Corp.	5116231f-82d1-44be-b08e-560c9a50e5c5	2023-08-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702 ndc (product): 60505-6152
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Proficient Rx LP	42ba7a9d-7d2b-4eac-af59-897151a8c924	2022-05-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
023Z5BR09K	CEFTRIAXONE SODIUM	104376-79-6	CEFTRIAXONE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1665021	cefTRIAXone 1 GM Injection	PSN	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665046	cefTRIAXone 2 GM Injection	PSN	5116231f-82d1-44be-b08e-560c9a50e5c5	11
309092	cefTRIAXone 250 MG Injection	PSN	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665005	cefTRIAXone 500 MG Injection	PSN	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665021	ceftriaxone 1000 MG Injection	SCD	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665046	ceftriaxone 2000 MG Injection	SCD	5116231f-82d1-44be-b08e-560c9a50e5c5	11
309092	ceftriaxone 250 MG Injection	SCD	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665005	ceftriaxone 500 MG Injection	SCD	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665021	ceftriaxone 1 GM (as ceftriaxone sodium) Injection	SY	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665046	ceftriaxone 2 GM (as ceftriaxone sodium) Injection	SY	5116231f-82d1-44be-b08e-560c9a50e5c5	11
309092	ceftriaxone 250 MG (as ceftriaxone sodium) Injection	SY	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	5116231f-82d1-44be-b08e-560c9a50e5c5	11
1665005	cefTRIAXone 500 MG Injection	PSN	53415af6-4072-4339-83e2-d870ae02a0e2	9
1665005	ceftriaxone 500 MG Injection	SCD	53415af6-4072-4339-83e2-d870ae02a0e2	9
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	53415af6-4072-4339-83e2-d870ae02a0e2	9
1665005	cefTRIAXone 500 MG Injection	PSN	cd8c0719-fa52-430d-a9f4-7b326de7a0ae	3
1665005	ceftriaxone 500 MG Injection	SCD	cd8c0719-fa52-430d-a9f4-7b326de7a0ae	3
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	cd8c0719-fa52-430d-a9f4-7b326de7a0ae	3
1665005	cefTRIAXone 500 MG Injection	PSN	9a937e47-8c36-4656-83e1-b3c18ed9bac3	2
1665005	ceftriaxone 500 MG Injection	SCD	9a937e47-8c36-4656-83e1-b3c18ed9bac3	2
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	9a937e47-8c36-4656-83e1-b3c18ed9bac3	2
1665005	cefTRIAXone 500 MG Injection	PSN	790279d4-2456-4091-abec-960b78885432	1
1665005	cefTRIAXone 500 MG Injection	PSN	f01cf0e5-caaf-4759-ba21-50f3aceff523	1
1665005	ceftriaxone 500 MG Injection	SCD	790279d4-2456-4091-abec-960b78885432	1
1665005	ceftriaxone 500 MG Injection	SCD	f01cf0e5-caaf-4759-ba21-50f3aceff523	1
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	790279d4-2456-4091-abec-960b78885432	1
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	f01cf0e5-caaf-4759-ba21-50f3aceff523	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
60505-6152-1	60505615201	10 VIAL, SINGLE-USE in 1 CARTON (60505-6152-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE	2017-06-30	0000-00-00	No	No	Current
60505-6152-4	60505615204	1 VIAL, SINGLE-USE in 1 CARTON (60505-6152-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE	2017-06-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Ceftriaxone for Injection, USP	Sportpharm LLC \| ASCLEMED USA INC. DBA ENOVACHEM	2026-04-24	HUMAN PRESCRIPTION DRUG LABEL	2
Ceftriaxone for Injection, USP	A-S Medication Solutions	2024-08-20	HUMAN PRESCRIPTION DRUG LABEL	9
Ceftriaxone for Injection, USP	REMEDYREPACK INC.	2024-04-03	HUMAN PRESCRIPTION DRUG LABEL	2
Ceftriaxone for Injection, USP	Proficient Rx LP	2024-02-01	HUMAN PRESCRIPTION DRUG LABEL	1
Ceftriaxone for Injection, USP	Asclemed USA, Inc. \| ASCLEMED USA INC. DBA ENOVACHEM	2023-09-02	HUMAN PRESCRIPTION DRUG LABEL	1
Ceftriaxone for Injection, USP	Apotex Corp. \| Qilu Pharmaceutical Co., Ltd. \| Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) \| Qilu Antibiotics Pharmaceutical Co., Ltd.	2023-08-31	HUMAN PRESCRIPTION DRUG LABEL	11
Ceftriaxone for Injection, USP	A-S Medication Solutions	2020-05-29	HUMAN PRESCRIPTION DRUG LABEL	3